Glaukos Long-Term Investments 2014-2025 | GKOS
Glaukos long-term investments from 2014 to 2025. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
- Glaukos long-term investments for the quarter ending March 31, 2025 were $0M, a 0% increase year-over-year.
- Glaukos long-term investments for 2024 were $0B, a 0% decline from 2023.
- Glaukos long-term investments for 2023 were $0B, a 0% decline from 2022.
- Glaukos long-term investments for 2022 were $0B, a 0% decline from 2021.
| Glaukos Annual Long-Term Investments (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $0 |
| 2021 | $0 |
| 2020 | $0 |
| 2019 | $0 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $0 |
| 2015 | $0 |
| 2014 | $0 |
| 2013 | $0 |
| Glaukos Quarterly Long-Term Investments (Millions of US $) |
|
|---|---|
| 2025-03-31 | |
| 2024-12-31 | |
| 2024-09-30 | |
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| 2016-03-31 | |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| 2015-03-31 | |
| 2014-12-31 | |
| 2014-09-30 | |
| 2014-06-30 | |
| 2014-03-31 | |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.358B | $0.383B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $182.012B | 22.03 |
| Intuitive Surgical (ISRG) | United States | $178.116B | 73.83 |
| Edwards Lifesciences (EW) | United States | $47.204B | 31.31 |
| IDEXX Laboratories (IDXX) | United States | $46.087B | 52.96 |
| Alcon (ALC) | Switzerland | $45.102B | 30.48 |
| DexCom (DXCM) | United States | $35.035B | 54.15 |
| IQVIA Holdings (IQV) | United States | $33.074B | 18.69 |
| Mettler-Toledo (MTD) | United States | $26.313B | 31.29 |
| STERIS (STE) | Ireland | $22.465B | 24.74 |
| Waters (WAT) | United States | $18.043B | 25.46 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.167B | 0.00 |
| Hologic (HOLX) | United States | $14.717B | 15.99 |
| Sysmex ADR (SSMXY) | Japan | $10.575B | 30.00 |
| Penumbra (PEN) | United States | $8.797B | 64.71 |
| Masimo (MASI) | United States | $8.618B | 31.79 |
| Globus Medical (GMED) | United States | $7.316B | 17.43 |
| Teleflex (TFX) | United States | $5.103B | 8.42 |
| Integer Holdings (ITGR) | United States | $3.826B | 19.09 |
| TransMedics (TMDX) | United States | $3.546B | 77.08 |
| PROCEPT BioRobotics (PRCT) | United States | $2.979B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.399B | 14.28 |
| Nihon Kohden (NHNKY) | Japan | $2.020B | 23.17 |
| Elekta AB (EKTAY) | Sweden | $1.937B | 17.41 |
| Veracyte (VCYT) | United States | $1.916B | 26.89 |
| Alphatec Holdings (ATEC) | United States | $1.590B | 0.00 |
| Artivion (AORT) | United States | $1.345B | 126.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.112B | 0.00 |
| OPKO Health (OPK) | United States | $1.071B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.999B | 5.31 |
| Pulse Biosciences (PLSE) | United States | $0.990B | 0.00 |
| SiBone (SIBN) | United States | $0.759B | 0.00 |
| IRadimed (IRMD) | United States | $0.735B | 37.29 |
| Beta Bionics (BBNX) | United States | $0.636B | 0.00 |
| AxoGen (AXGN) | United States | $0.612B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.548B | 8.53 |
| OrthoPediatrics (KIDS) | United States | $0.541B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.505B | 10.86 |
| Pacific Biosciences Of California (PACB) | United States | $0.462B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.452B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.422B | 9.82 |
| Delcath Systems (DCTH) | United States | $0.380B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.371B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.352B | 0.00 |
| RxSight (RXST) | United States | $0.318B | 0.00 |
| Neuronetics (STIM) | United States | $0.296B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.295B | 0.00 |
| NeuroPace (NPCE) | United States | $0.288B | 0.00 |
| 908 Devices (MASS) | United States | $0.249B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.246B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.240B | 14.52 |
| CVRx (CVRX) | United States | $0.215B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.202B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.179B | 0.00 |
| Inogen (INGN) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.164B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Accuray (ARAY) | United States | $0.154B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.121B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.119B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.117B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.115B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.088B | 53.30 |
| EnVVeno Medical (NVNO) | United States | $0.086B | 0.00 |
| Hyperfine (HYPR) | United States | $0.082B | 0.00 |
| InspireMD (NSPR) | United States | $0.075B | 0.00 |
| Spectral AI (MDAI) | United States | $0.064B | 0.00 |
| Positron (POSC) | United States | $0.060B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.055B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.054B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.052B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.022B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.013B | 0.00 | |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 14.94 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |